Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

privacy

- PMLiVE

AstraZeneca embarks on oncology research access project

Invites companies to join molecular data resource consortium

- PMLiVE

EMA suspends generic drugs on data integrity concerns

Reports by FDA and WHO find evidence of data manipulation by Semler Research Centre

- PMLiVE

The Netherlands leads Europe for future health

And benchmarking report finds UAE best placed to meet healthcare challenges

- PMLiVE

Cuttsy and Cuttsy launches campaign celebrating healthcare industry

Encourages people to share positive experiences online

In Memory

In Memory is a pioneering new short film that exemplifies Bedrock Multimedia’s industry leading approach to healthcare edutainment. It provides a captivating example of how film can be used to...

Bedrock Healthcare Communications

- PMLiVE

Tracking comms trends: 2 + 2 = 7: bad maths, or good sense?

From multi-disciplinary teamwork to pharma’s reputation, value and access to global briefs, our contributors tackle some of the key topics in communications today

Celgene building

Celgene forms real-time, real-world trial partnership

Will collaborate with TriNetX, using its electronic medical records network

- PMLiVE

Healthcare costs

The technology poised to drive down the cost of healthcare

Case study: Understanding Patient Willingness to Pay in Emerging Markets

Our client wanted to identify the optimum selling price for their chronic disease treatment in emerging markets, based on patient’s willingness to pay for the product out of pocket.Find out...

Research Partnership

- PMLiVE

Coming to an understanding

EphMRA’s Dr Thomas Hein on how market research in pharma has been changing

- PMLiVE

The hitchhiker’s guide to the millennial healthcare professional

Originally written in the late 1970s, Douglas Adams’ well-loved sci-fi masterpiece, The Hitchhiker’s Guide To The Galaxy, tells the story of Arthur Dent as he flees Earth shortly before it’s...

China flag thumb

Chinese biotech claims 90% cure rate for CAR-T therapy

Innovative Cellular Therapeutics presents ‘stellar’ immunotherapy data

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links